These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 11952807

  • 1. Endothelin ETA receptor-subtype specific antagonism does not mitigate the acute systemic or renal effects of exogenous angiotensin II in humans.
    Bayerle-Eder M, Langenberger H, Pleiner J, Polska E, Mensik C, Eichler HG, Wolzt M, Schmetterer L.
    Eur J Clin Invest; 2002 Apr; 32(4):230-5. PubMed ID: 11952807
    [Abstract] [Full Text] [Related]

  • 2. Systemic and renal effects of an ET(A) receptor subtype-specific antagonist in healthy subjects.
    Schmetterer L, Dallinger S, Bobr B, Selenko N, Eichler HG, Wolzt M.
    Br J Pharmacol; 1998 Jul; 124(5):930-4. PubMed ID: 9692778
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of BQ-123, an endothelin antagonist, on renal hemodynamics, tubular function, vasoactive hormones, and blood pressure in healthy humans: a dose response study.
    Pedersen EB, Thomsen IM, Fjordside LS.
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1578-85. PubMed ID: 16364829
    [Abstract] [Full Text] [Related]

  • 5. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
    Spratt JC, Goddard J, Patel N, Strachan FE, Rankin AJ, Webb DJ.
    Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade.
    Goddard J, Johnston NR, Hand MF, Cumming AD, Rabelink TJ, Rankin AJ, Webb DJ.
    Circulation; 2004 Mar 09; 109(9):1186-93. PubMed ID: 14981006
    [Abstract] [Full Text] [Related]

  • 8. Contribution of endothelin to renal vascular tone and autoregulation in the conscious dog.
    Berthold H, Münter K, Just A, Kirchheim HR, Ehmke H.
    Am J Physiol; 1999 Mar 09; 276(3):F417-24. PubMed ID: 10070165
    [Abstract] [Full Text] [Related]

  • 9. Hemodynamic, renal, and endocrine responses to acute ET(A) blockade at different ANG II plasma levels.
    Boemke W, Hocher B, Schleyer N, Krebs MO, Kaczmarczyk G.
    Am J Physiol Regul Integr Comp Physiol; 2001 May 09; 280(5):R1322-31. PubMed ID: 11294750
    [Abstract] [Full Text] [Related]

  • 10. Opposing effects of angiotensin II on muscle and renal blood flow under euglycemic conditions.
    Fliser D, Dikow R, Demukaj S, Ritz E.
    J Am Soc Nephrol; 2000 Nov 09; 11(11):2001-2006. PubMed ID: 11053475
    [Abstract] [Full Text] [Related]

  • 11. Endothelin-A receptors mediate renal hemodynamic effects of exogenous Angiotensin II in humans.
    Montanari A, Biggi A, Carra N, Ziliotti M, Fasoli E, Musiari L, Perinotto P, Novarini A.
    Hypertension; 2003 Oct 09; 42(4):825-30. PubMed ID: 12925560
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of endothelin receptor antagonists on renal hemodynamics in angiotensin II-infused rats on high NaCl intake.
    Saeed A, Dibona GF, Guron G.
    Kidney Blood Press Res; 2012 Oct 09; 36(1):258-67. PubMed ID: 23171921
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intrarenal infusion of angiotensin-(1-7) modulates renal functional responses to exogenous angiotensin II in the rat.
    Bürgelová M, Kramer HJ, Teplan V, Velicková G, Vítko S, Heller J, Malý J, Cervenka L.
    Kidney Blood Press Res; 2002 Oct 09; 25(4):202-10. PubMed ID: 12424421
    [Abstract] [Full Text] [Related]

  • 16. Selective ET(A) receptor antagonism with ABT-627 attenuates all renal effects of endothelin in humans.
    Honing MLH, Hijmering ML, Ballard DE, Yang YP, Padley RJ, Morrison PJ, Rabelink TJ.
    J Am Soc Nephrol; 2000 Aug 09; 11(8):1498-1504. PubMed ID: 10906163
    [Abstract] [Full Text] [Related]

  • 17. Cholesterol feeding does not alter renal hemodynamic response to acetylcholine and angiotensin II in rabbits.
    Carroll JF, Mizelle HL, Cockrell K, Reckelhoff JF, Clower BR, Granger JP.
    Am J Physiol; 1997 Mar 09; 272(3 Pt 2):R940-7. PubMed ID: 9087658
    [Abstract] [Full Text] [Related]

  • 18. Fractional urinary excretion of endothelin-1 is reduced by acute ETB receptor blockade.
    Goddard J, Johnston NR, Cumming AD, Webb DJ.
    Am J Physiol Renal Physiol; 2007 Nov 09; 293(5):F1433-8. PubMed ID: 17855483
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin II sensitivity is associated with the angiotensin II type 1 receptor A(1166)C polymorphism in essential hypertensives on a high sodium diet.
    Spiering W, Kroon AA, Fuss-Lejeune MM, Daemen MJ, de Leeuw PW.
    Hypertension; 2000 Sep 09; 36(3):411-6. PubMed ID: 10988274
    [Abstract] [Full Text] [Related]

  • 20. Renal actions of endothelin-1 in newborn piglets: dose-effect relation and the effects of receptor antagonist (BQ-123) and cyclooxygenase inhibitor (indomethacin).
    Bhat R, John E, Chari G, Shankararao R, Fornell L, Gulati A, Vidyasagar D.
    J Lab Clin Med; 1995 Nov 09; 126(5):458-69. PubMed ID: 7595031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.